Study to Evaluate the Performance & Safety of the Medical Device Argogen

Status Not yet recruiting

Clinical Trial Summary

A wound, i.e., a break in the skin, can result from several reasons. Pressure ulcers (also called pressure sores, bed sores and decubitus ulcers) are localized damage to the skin and underlying soft tissue usually over a bony prominence or related to a medical or other device, occurring as a result of intense and/or prolonged pressure or pressure in combination with shear. Burn wounds result from traumatic injuries to the skin or other tissues primarily caused by heat, electrical discharge, friction, chemicals, or radiation. Burns are acute wounds caused by an isolated, non-recurring insult. The Medical Device Argogen® (adsorbing spray powder for exudates with silver ions) consists of silver zeolite powder, combining in a single physical form the adsorbing properties of the zeolite structure and the antimicrobial properties of silver. Its action is due to the porous structure of zeolite that actively absorbs and control wounds exudate, keeping clean and dry the environment of small skin lesions, as wounds, abrasions, minor burns and bedsores. The association with silver ions gives to the medical device the additional property of an antimicrobial effect. The present study is to confirm that in a population of men and women presenting minor burn wounds (superficial or superficial / deep partial thickness) or chronic pressure ulcers stage 2 or 3 - NPUAP Classification (partial-thickness skin loss with exposed dermis or full-thickness skin loss) the medical device already CE marked Argogen® (adsorbing spray powder for exudates with silver ions) safely attests its capacity to promote wound healing, evaluated as percentage (%) of subjects with objective signs of wound healing (evaluated by mean of VSS score reduction for burn wounds or PUSH tool score reduction for pressure ulcers), results observed after 2 and 4 weeks after the beginning of the treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05649332
Study type	Interventional
Source	Signorini Medicale S.r.l.
Contact	Dionisio F Barattini, MD
Phone	+40774012684
Email	franco.barattini@tigermedgrp.com
Status	Not yet recruiting
Phase	N/A
Start date	May 1, 2023
Completion date	September 7, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03948360` - Safety Study of a Novel Wearable Phototherapy System for the Management of Acute Burn Wounds	N/A
Completed	`NCT04277182` - Effect of Propolis Application on Burn Healing	N/A
Enrolling by invitation	`NCT00978705` - Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood	Phase 3
Withdrawn	`NCT03675568` - Non-cultured Autologous Keratinocyte Suspension Versus Traditional Split Skin Graft for Burn Wounds Treatment	N/A
Active, not recruiting	`NCT04828304` - PLASOMA Ultimate Safety & Efficacy Study	N/A
Recruiting	`NCT05593523` - Fluorescence-based Detection of Inflammation and Necrosis to Inform Surgical Decision-making and Enhance Outcomes
Completed	`NCT06280053` - HealiAid in the Treatment of Different Wounds	N/A
Enrolling by invitation	`NCT06103409` - MSCs for the Treatment of Burn Wounds	Phase 1/Phase 2
Recruiting	`NCT05796492` - Ultrasound Treatment on Wound Healing Time	N/A
Enrolling by invitation	`NCT04725071` - Immunonutrition Supplementation for Improved Burn Wound Healing in Older Adults	N/A
Suspended	`NCT02577120` - Wound Healing Endpoint and Recurrence	Phase 4
Active, not recruiting	`NCT05341427` - DEVELOPMENT OF A CLINICAL PREDICTION RULES TO IDENTIFY EFFICACY OF PULSED ELECTROMAGNETIC THERAPY ON BURN WOUND HEALING	N/A
Completed	`NCT04753723` - The Use of a Platform Wound Device for Reducing Infection	Phase 4
Terminated	`NCT03723590` - A Clinical Evaluation of an Esterified Hyaluronic Acid Matrix in Burn Patients for STSG	N/A
Not yet recruiting	`NCT04011306` - A Feasibility Study of a Novel Phototherapy System for the Management of Acute Burns	N/A
Recruiting	`NCT05404191` - Prediction Rules for Low Level Laser on Burn Wounds	N/A
Completed	`NCT02982096` - Study Comparing Healing With Epidermal Fractional Blistergrafting (CellutomeTM) to Acellular Technique	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Study to Evaluate the Performance and Safety of the Medical Device Argogen

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms